RAAJ MEDISAFE INDIA LTD.

Raaj Medisafe India Ltd announced the closure of its trading window for promoters, directors, designated employees, and their immediate relatives. This closure, effective from October 1, 2026, will remain in effect until 48 hours after the declaration of the unaudited financial results for the quarter ending September 30, 2026. The company stated this action is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The date for the Board Meeting to consider these results will be announced later.

Brahma Swaroop Jajoo, a promoter of Raaj Medisafe India Ltd, has transferred 1.19% of the company's shares (1,94,700 shares) to Vishnu Jajoo HUF through a gift via off-market inter-se transfer. This transaction does not alter the aggregate holding of the promoter and promoter group. The disclosure was made in compliance with SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Raaj Medisafe India Ltd has filed a disclosure under SEBI (SAST) Regulations, 2011, regarding a transfer of 26,993 equity shares (0.16% of total share capital) by Promoter Krishna Jajoo to Vishnu Jajoo HUF via an off-market gift. This transaction is an inter-se transfer among promoters, and the aggregate holding of the Promoter and Promoter Group remains unchanged. The total equity share capital of the company is Rs. 16,42,43,120.

Vishnu Jajoo HUF has disclosed the transfer of 2,21,693 equity shares, representing 1.35% of the total share capital, in Raaj Medisafe India Ltd via an off-market inter-se transfer by way of gift. The transfer was between promoter group entities. The disclosure under SEBI (SAST) Regulations, 2011, confirms that the aggregate holding of the Promoter and Promoter Group remains unchanged as a result of this transaction.

Raaj Medisafe India Ltd has received a Letter of Award from Madhya Pradesh Public Health Services Corporation Limited for the supply of 29,88,220 units of Baby Diapers (Small). The order, valued at approximately ₹17.02 Crores inclusive of GST, requires delivery to various government hospitals in Madhya Pradesh within 18 months from the contract date. This significant contract is expected to boost the company's revenue and market presence in the healthcare sector.

Raaj Medisafe India Ltd has announced its 41st Annual General Meeting (AGM) will be held on Monday, September 21, 2026, at 3:00 PM IST. The meeting will be conducted through Video Conferencing/OAVM. Key agenda items include the adoption of the Audited Financial Statements for the financial year ended March 31, 2026, the re-appointment of Shri Arpit Bangur as a Director, and a special resolution to allow Smt. Krishna Jajoo to continue as a Non-Executive Non-Independent Director beyond the age of 75. The company has also made arrangements for e-voting, with the cut-off date set for September 14, 2026, and voting commencing on September 18, 2026.

Raaj Medisafe India Ltd has submitted its Annual Report for the financial year 2025-26, in compliance with Regulation 34(1) of SEBI (LODR) Regulations, 2015. The report includes the audited financial statements, Board of Directors' and Auditors' reports, and the notice for the 41st Annual General Meeting (AGM). The AGM is scheduled for September 21, 2026, at 3:00 PM, to be conducted via Video Conferencing/OAVM. The company is facilitating remote e-voting and e-attendance for its members through CDSL. Key agenda items include the adoption of financial statements and the re-appointment of Shri Arpit Bangur as a Director. Additionally, the AGM will consider the continuation of Smt. Krishna Jajoo as a Non-Executive Non-Independent Director, who will be attaining the age of 75.

Raaj Medisafe India Ltd has announced its unaudited financial results for the quarter ended June 30, 2026. The company's Board of Directors approved these results on August 12, 2026, following a limited review by statutory auditors GDK & Associates. The results cover standalone financial performance and segment-wise reporting for the Plastics and Hygiene divisions. Previous period figures have been reclassified for comparability. The financial statements are prepared in accordance with Indian Accounting Standards (Ind AS).

Raaj Medisafe India Ltd has submitted a statement of deviation/variation in the utilization of funds raised via preferential allotment on March 26, 2026. The funds, amounting to ₹18,01,25,000, were raised for acquisition of plant and machinery, business operations of Fabrizo Industries, company expansion, working capital, and general corporate purposes. For the quarter ended June 30, 2026, the company reported no deviation or variation in the utilization of these funds. The statement was reviewed by the Audit Committee on August 12, 2026.

Raaj Medisafe India Ltd announced the appointment of Mr. Vipul Parakh as the new Chief Financial Officer (CFO) of the company. The decision was made during the Board of Directors meeting held on August 12, 2026. Mr. Parakh is a Chartered Accountant with over 28 years of extensive experience in financial operations, reporting, budgeting, compliance, and strategic financial planning across service and manufacturing sectors. His appointment is effective from the date of the board meeting.